Zobrazeno 1 - 10 of 514 pro vyhledávání: '"PJ Mease"'
4
Akademický článek
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study.
Autor: Østergaard M; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: mo@dadlnet.dk., Boesen M; Department of Radiology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark., Maksymowych WP; Department of Medicine, University of Alberta, Edmonton, AB, Canada., Lambert RG; Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada., Bubb MR; Division of Immunology and Rheumatology, University of Florida, Gainesville, FL, USA., Kubassova O; Image Analysis Group, Philadelphia, PA, USA., Valenzuela G; Integral Rheumatology and Immunology Specialists, Plantation, FL, USA., Reddy J; Amgen, Thousand Oaks, CA, USA., Colgan S; Amgen, Thousand Oaks, CA, USA., Klyachkin Y; Amgen, Thousand Oaks, CA, USA., Deignan C; Amgen, Thousand Oaks, CA, USA., Zhou Z; Amgen, Thousand Oaks, CA, USA., Amouzadeh H; Amgen, Thousand Oaks, CA, USA., Mease PJ; Swedish Medical Center-Providence St Joseph Health, School of Medicine, University of Washington, Seattle, WA, USA.
Publikováno v: The Lancet. Rheumatology [Lancet Rheumatol] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.
Zobrazit plný text záznamu
5
Akademický článek
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial.
Autor: Gossec L; INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France laure.gossec@aphp.fr.; Pitié Salpêtrière Hospital, Rheumatology Department, AP-HP, Paris, France., Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Gladman DD; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada., Aelion JA; West Tennessee Research Institute, Jackson, Tennessee, USA., Vasandani J; West Texas Clinical Research, Lubbock, Texas, USA., Pinter A; Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany., Merola JF; Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas, Texas, USA., Kavanaugh A; School of Medicine, University of California San Diego, La Jolla, California, USA., Reddy J; Amgen Inc, Thousand Oaks, California, USA., Wang R; Amgen Inc, Thousand Oaks, California, USA., Brunori M; Amgen Inc, Thousand Oaks, California, USA., Klyachkin Y; Amgen Inc, Thousand Oaks, California, USA., Deignan C; Amgen Inc, Thousand Oaks, California, USA., Mease PJ; Providence St. Joseph Health, Swedish Medical Center, Seattle, Washington, USA.; University of Washington School of Medicine, Seattle, Washington, USA.
Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Oct 21; Vol. 83 (11), pp. 1480-1488. Date of Electronic Publication: 2024 Oct 21.
Zobrazit plný text záznamu
6
Akademický článek
Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: Achievement of minimal disease activity components in a phase 2 trial.
Autor: Kavanaugh A; Department of Medicine, University of California, San Diego, School of Medicine, La Jolla, CA, USA., Coates LC; Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Mease PJ; Department of Rheumatology, Swedish Medical Center/Providence St Joseph Health and University of Washington, Seattle, WA, USA., Nowak M; Bristol Myers Squibb, Princeton, NJ, USA., Hippeli L; Bristol Myers Squibb, Princeton, NJ, USA., Lehman T; Bristol Myers Squibb, Princeton, NJ, USA., Banerjee S; Bristol Myers Squibb, Princeton, NJ, USA., Merola JF; Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas, TX, USA.
Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.
Zobrazit plný text záznamu
7
Akademický článek
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies.
Autor: Navarro-Compán V; V. Navarro-Compán, MD, PhD, MSc, Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain., Rudwaleit M; M. Rudwaleit, MD, University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany., Dubreuil M; M. Dubreuil, MD, MSc, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA., Magrey M; M. Magrey, MD, Case Western Reserve University, University Hospitals, Cleveland, Ohio, USA., Marzo-Ortega H; H. Marzo-Ortega, LMS, PhD, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Mease PJ; P.J. Mease, MD, Swedish Medical Center and Providence St. Joseph Health and University of Washington, Seattle, Washington, USA., Walsh JA; J.A. Walsh, MD, Division of Rheumatology, Salt Lake City Veterans Affairs Health and University of Utah Health, Salt Lake City, Utah, USA., Dougados M; M. Dougados, MD, PhD, Department of Rheumatology, Hôpital Cochin, University of Paris Cité, Paris, France., de la Loge C; C. de la Loge, MSc, Brussels, Belgium., Fleurinck C; C. Fleurinck, MD, UCB, Brussels, Belgium., Massow U; U. Massow, PhD, UCB, Monheim am Rhein, Germany., Vaux T; T. Vaux, MSc, UCB, Slough, UK., Taieb V; V. Taieb, MSc, UCB, Colombes, France., Deodhar A; A. Deodhar, MD, MRCP, Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, Oregon, USA.
Publikováno v: The Journal of rheumatology [J Rheumatol] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.
Zobrazit plný text záznamu
8
Akademický článek
Persistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Year, Phase 3, Randomized, Controlled Study.
Autor: Mease PJ; Providence Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington., Baraliakos X; Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany., Chandran V; University of Toronto and Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada., Soriano ER; Hospital Italiano de Buenos Aires and University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Nash P; Griffith University and University of Queensland, Maroochydore, Queensland, Australia., Deodhar A; Oregon Health & Science University, Portland, Oregon., Rampakakis E; McGill University and JSS Medical Research, Inc, Montreal, Quebec, Canada., Shiff NJ; Janssen Scientific Affairs, LLC, A Johnson & Johnson Company, Horsham, Pennsylvania, and University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Chakravarty SD; Janssen Scientific Affairs, LLC, A Johnson & Johnson Company, Horsham, Pennsylvania, and Drexel University College of Medicine, Philadelphia, Pennsylvania., Shawi M; Janssen Research & Development, LLC, Titusville, New Jersey., Merola JF; University of Texas Southwestern Medical Center, Dallas, Texas., McInnes IB; College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Publikováno v: ACR open rheumatology [ACR Open Rheumatol] 2024 Oct 04. Date of Electronic Publication: 2024 Oct 04.
Zobrazit plný text záznamu
9
Akademický článek
The 1st GRAPPA International Meeting on Psoriasis and Psoriatic Arthritis - 1º Encontro Internacional do GRAPPA sobre Psoríase e Artrite Psoriásica.
Autor: Goldenstein-Schainberg C; Claudia Goldenstein-Schainberg, MD, PhD, Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., da Silva DLF; Dimitri Luz Felipe da Silva, MD, MSc, Departamento de Dermatologia, Universidade Santo Amaro, UNISA, São Paulo, Brazil., Soriano ER; Enrique R. Soriano, MD, MSc, Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, and Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Savage LJ; Laura J. Savage, MBChB BSc(Hons), PhD, Leeds Teaching Hospitals NHS Trust, and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Mease PJ; Philip J. Mease, MD, Rheumatology Research, Providence Swedish Medical Center, and University of Washington School of Medicine, Washington, Seattle, USA.
Publikováno v: The Journal of rheumatology [J Rheumatol] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.
Zobrazit plný text záznamu
10
Akademický článek
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry.
Autor: Mease PJ; Department of Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, USA., Blauvelt A; Oregon Medical Research Center, Portland, OR, USA., Sima AP; CorEvitas, LLC, Waltham, MA, USA., Beaty SW; UCB, Inc., Smyrna, GA, USA., Low R; UCB, Inc., Smyrna, GA, USA., Gomez B; UCB, Inc., Smyrna, GA, USA., Gurrola M; CorEvitas, LLC, Waltham, MA, USA., Lebwohl MG; Department of Dermatology, Mount Sinai-The Icahn School of Medicine at Mt. Sinai, 5 East 98th St 5th Fl, New York, NY, 10029, USA. lebwohl@aol.com.
Publikováno v: Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Oct; Vol. 14 (10), pp. 2805-2825. Date of Electronic Publication: 2024 Sep 16.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje